Clinics in Dermatology
Volume 28, Issue 5 , Pages 478-482 , September 2010

The role of Helicobacter pylori infection in skin diseases: Facts and controversies

  • Yalçın Tüzün, MD

      Affiliations

    • Corresponding Author InformationCorresponding author. Fax: +90 212 587 0505.
    • ,
  • Sadiye Keskin, MD

      Affiliations

    • Corresponding Author InformationCorresponding author. Fax: +90 212 587 0505.
    • ,
  • Eneida Kote, MD

      Affiliations

    • Corresponding Author InformationCorresponding author. Fax: +90 212 587 0505.

References 

  1. Tsang KW, Lam SK. Extragastroduodenal conditions associated with Helicobacter pylori infection. Hong Kong Med J. 1999;5:169–174
  2. Shitoni A, Okada K, Yanaoka K, et al. Beneficial effect of Helicobacter pylori eradication in dermatological diseases. Helicobacter. 2001;6:60–65
  3. Pakodi F, Abdel-Salam OME, Debreceni A, Mozsik G. Helicobacter pylori. One bacterium and a broad spectrum of human disease! An overview. J Physiol. 2000;94:139–152
  4. Argenziano G, Donarumma G, Iovene MR, Arnese P, Baldassare AM, Baroni A. Incidence of anti-Helicobacter pylori and anti-CagA antibodies in rosacea patients. Int J Dermatol. 2003;42:601–604
  5. Szlachcic A. The link between Helicobacter pylori infection and rosacea. J Eur Acad Dermatol Venereol. 2002;16:328–333
  6. de Miquel DB, Romero MV, Sequeiros EV, et al. Effect of Helicobacter pylori eradication therapy in rosacea patients. Rev Esp Enferm Dig. 2006;98:501–509
  7. Rebora A, Drago F, Picciotto A. Helicobacter pylori in patients with rosacea. Am J Gastroenterol. 1994;89:1603–1604
  8. Jones MP, Knable AL, White MJ, Durning SJ. Helicobacter pylori in rosacea: lack of an association. Arch Dematol. 1998;134:511
  9. Sharma VK, Lynn A, Kamiñski M, Vasudeva R, Howden CW. A study of the prevalence of Helicobacter pylori infection and other markers of upper gastrointestinal tract disease in patients with rosacea. Am J Gastroenterol. 1998;93:220–222
  10. Utas S, Özbakir O, Turasan A, Utas C. Helicobacter pylori eradication treatment reduces the severity of rosacea. J Am Acad Dermatol. 1999;40:433–435
  11. Gürer MA, Erel A, Erbaş D, Çağlar K, Atahan Ç. The seroprevalence of Helicobacter pylori and nitric oxide in acne rosacea. Int J Dermatol. 2002;41:768–770
  12. Dauden E, Jimenez-Alonso I, Garcia-Diez A. Helicobacter pylori and idiopathic chronic urticaria. Int J Dermatol. 2000;39:446–452
  13. Wedi B, Wagner S, Werfel T, et al. Prevelance of Helicobacter pylori-associated gastritis in chronic urticaria. Int Arch Allergy Immunol. 1998;116:288–294
  14. Becker H, Meyer M, Paul E. Remission ratio of chronic urticaria-spontaneous healing or result of eradication of Helicobacter pylori infection?. Hauzart. 1998;49:907–911
  15. Howden C. No evidence for an association between H. pylori and idiopathic chronic urticaria. Dig Dis Sci. 1999;44:485–486
  16. Di Campli C, Gasbarrini A, Nucera E, et al. Benifical effects of Helicobacter pylori eradication on idiopathic chronic urticaria. Dig Dis Sci. 1998;43:1226–1229
  17. Schnyder B, Helbling A, Pichler W. Chronic idiopathic urticaria: natural course and association with Helicobacter pylori infection. Int Arch Allergy Immunol. 1999;119:60–63
  18. Hizal M, Tüzün B, Wolf R, Tüzün Y. The relationship between Helicobacter pylori IgG antibody and autologous serum test in chronic urticaria. Int J Dermatol. 2000;39:443–445
  19. Schrutka-Koebl CH, Wasilewicz–Stephani G, Gschwantler M, et al. Has eradication therapy an effect in Helicobacter-positive patients with chronic urticaria?. Am J Gastroenterol. 1998;93:2632–2633
  20. Valsecchi R, Pigatto P. Chronic urticaria and Helicobacter pylori. Acta Derm Venereol. 1998;78:440–442
  21. Polat H, Balevi Ş, Güney İ, Hidayetoğlu T, Kayaçetin E. Kronik idiyopatik ürtikerli hastalarda Helikobakter pilori. Genel Tıp Derg. 2002;1:13–16
  22. Qayoom S, Ahmad QM. Psoriasis and Helicobacter pylori. Indian J Dermatol Venereol Leprol. 2003;69:133–134
  23. Ali M, Whitehead M. Clearence of chronic psoriasis after eradication therapy for Helicobacter pylori infection. J Eur Acad Dermatol Venereol. 2008;22:753–754
  24. Ersoy O, Ersoy R, Yayar Ö, Demirci H, Tatlican S. H pylori infection in patients with Behçet's disease. World J Gastroenterol. 2007;13:2983–2985
  25. Bogle MA, Riddle CC, Triana EM, Jones D, Duvic M. Primary cutaneous B-cell lymphoma. J Am Acad Dermatol. 2005;53:479–484
  26. Visy B, Füst G, Bygum A, Bork K, et al. Helicobacter pylori infection as a triggering factor of attacks in patients with hereditary angioedema. Helicobacter. 2007;12:251–257
  27. Rais M, Unzeitig J, Grant JA. Refractory exacerbations of hereditary angioedema with associated Helicobacter pylori infection. J Allergy Clin Immunol. 1999;103:713–714
  28. Farkas H, Füst G, Fekete B, Karadi I, Varga L. Eradication of Helicobacter pylori and improvement of hereditary angioneurotic oedema. Lancet. 2001;358:1695–1696
  29. Varvarovska J, Sykora J, Stozicky F, Chytra I. Acquired angioedema and Helicobacter pylori infection in a child. Eur J Pediatr. 2003;162:707–709
  30. Dauden E, Vasquez-Carrasco MA, Penas PF, Pajares JM, Garcia-Diez A. Association of Helicobacter pylori infection with psoriasis and lichen planus: prevalence and effect of eradication therapy. Arch Dermatol. 2000;136:1275–1276
  31. Saes-Rodriguez M, Noda-Cabrera A, Garcia-Bustinduy M, et al. Palmoplantar pustulosis associated with gastric Helicobacter pylori infection. Clin Exp Dermatol. 2002;27:720

PII: S0738-081X(10)00026-X

doi: 10.1016/j.clindermatol.2010.03.002

Clinics in Dermatology
Volume 28, Issue 5 , Pages 478-482 , September 2010

Article Tools